89bio, Inc.
ETNBDelisted Oct 30, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785173
89bio, Inc. was delisted on Oct 30, 2025; its insiders filed their last Form 4 on Nov 3, 2025; 198 institutions reported holding it in 13F filings for Q3 2025, worth $2.27B in total; no superinvestor held it.
Q4 2024 vs. Q3 2024
How the institutions holding 89bio, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 144 | 2 | 156 | +14 |
| Shares | 104.5M | 402.8K | 121.3M | +17.2M (+16.5%) |
| Value | $773.8M | $2.98M | $948.7M | +$177.8M (+23.1%) |
2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (33)
Institutions that held 89bio, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
Sold out (19)
Institutions that held 89bio, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| ExodusPoint Capital Management, LP | 871,404 | $6.45M |
| Franklin Resources Inc | 504,563 | $3.99M |
| MPM Oncology Impact Management LP | 330,000 | $2.44M |
| Jacobs Levy Equity Management, Inc | 130,894 | $968.6K |
| Nomura Holdings Inc | 99,997 | $740.0K |
| Alps Advisors Inc | 81,349 | $602.0K |
| Voloridge Investment Management, LLC | 80,904 | $598.7K |
| HighVista Strategies LLC | 66,787 | $494.2K |
| Trexquant Investment LP | 54,389 | $402.5K |
| Tudor Investment Corp Et Al | 46,617 | $345.0K |
| Quest Partners LLC | 22,074 | $163.3K |
| Prudential Financial Inc | 21,815 | $161.4K |
| Engineers Gate Manager LP | 21,142 | $156.5K |
| Dynamic Technology Lab Private Ltd | 21,096 | $156.0K |
| Brevan Howard Capital Management LP | 14,259 | $105.5K |
| Squarepoint Ops LLC | 12,617 | $93.4K |
| Simplex Trading, LLC | 7,925 | $58.0K |
| Clearstead Advisors, LLC | 177 | $1.31K |
| Bessemer Group Inc | 130 | $1.00K |
Not filed for Q4 2024 yet (2)
Institutions that held 89bio, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Raymond James & Associates | 227,953 | $1.69M |
| Raymond James Financial Services Advisors, Inc. | 174,857 | $1.29M |